Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5567492 | 0.89 | KMT2A (0.41) | KMT2AMEN1SMN1; SMN2ALDH1A1ATM | |
| SCHEMBL6052997 | 0.87 | EPHX2 (0.39) | KMT2AMEN1ALDH1A1ATMMAPT | |
| SCHEMBL4282405 | 0.81 | KMT2A (0.37) | KMT2AMEN1ALDH1A1ATMMAPT | |
| SCHEMBL658754 | 0.77 | GRIN2D (0.53) | KMT2AMEN1ALDH1A1ATMMAPT | |
| SCHEMBL5569530 | 0.76 | KMT2A (0.36) | KMT2AMEN1SMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL60897 | 0.69 | GRIN2D (0.48) | KMT2AMEN1SMN1; SMN2L3MBTL1GRIN2D | |
| SCHEMBL11807192 | 0.69 | KMT2A (0.55) | KMT2ASMN1; SMN2ALDH1A1EPHX2LMNA | |
| SCHEMBL3188537 | 0.69 | GRIN2D (0.50) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL12226580 | 0.67 | EPHX2 (0.39) | KMT2ASMN1; SMN2EPHX2LMNA | |
| SCHEMBL4290590 | 0.67 | EPHX2 (0.48) | KMT2AMEN1SMN1; SMN2GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009156161-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMINOADAMANTANE DERIVATIVES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-12-30 | — | — | WO | disclosed |
| EP-1732530-A1 | 1-AMINOVYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF AGITATION AND OTHER BEHAVIORAL DISORDERS, ESPECIALLY THOSE ASSOCIATED WITH ALZHEIMER'S DISEASE | Merz Pharma GmbH & Co.KGaA (DE) | 2006-12-20 | — | — | EP | disclosed |
| EP-1682109-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC AS PEPTIDES IN AMYLOIDOPATHIES | Merz Pharma GmbH & Co. KGaA (DE) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005084655-A1 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF AGITATION AND OTHER BEHAVIORAL DISORDERS, ESPECIALLY THOSE ASSOCIATED WITH ALZHEIMER’S DISEASE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005079779-A1 | THE USE OF 1-AMINOCYCLOHEXANE DERIVATIVES TO MODIFY DEPOSITION OF FIBRILLOGENIC Aß PEPTIDES IN AMYLOIDOPATHIES | MERZ PHARMA GMBH & CO. KGAA (DE) | 2005-09-01 | — | — | WO | disclosed |